Added to YB: 2026-01-14
Pitch date: 2026-01-10
TEM [bullish]
Tempus AI, Inc.
-10.87%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
Market Cap
$11.8B
Pitch Price
$75.34
Price Target
150.00 (+117%)
Dividend
N/A
EV/EBITDA
-78.13
P/E
-55.73
EV/Sales
11.19
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI- $TEM: Building the Foundational Data Platform for AI Driven Medicine
TEM: Precision medicine platform w/ 400 petabytes multimodal data from 40M+ patients. Q3 rev $334M (+85% YoY), targeting $1.3B 2025 (+80% YoY). First adj EBITDA+ quarter, path to GAAP profitability 2026-27. Bull case: data flywheel, pharma partnerships, regulatory wins. Bear: reimbursement risk, dilution from converts. DCF: $95 fair value vs ~$68 current. Strong platform compounding story if patient w/ volatility.
Read full article (12 min)